Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170101031697N3Phase 3Completed
Phase 3, randomised, double-blind trial of dexmedetomidine, ketamine and pethidine (4 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Degree of shivering. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170101031697N3.